[1]
|
Watson, J.D. and Crick, F.H.C. (1953) A Structure for Deoxyribose Nucleic Acid. Nature, 171, 737-738. https://doi.org/10.1038/171737a0
|
[2]
|
Watson, J.D., Baker, T.A., Bell, S.P., Gann, A., Levine, M., Losik, R., et al. (2014) Molecular Biology of the Gene. 7th Edition, Benjamin-Cummings Publishing Company, Boston.
|
[3]
|
Pertea, M. and Salzberg, S.L. (2010) Between a Chicken and a Grape: Estimating the Number of Human Genes. Genome Biology, 11, 206.
|
[4]
|
Wilusz, J.E., Sunwoo, H. and Spector, D. (2009) Long Noncoding RNAs: Functional Surprises from the RNA World. Genes & Development, 23, 1494-1504.
https://doi.org/10.1101/gad.1800909
|
[5]
|
Mattick, J.S. and Makunin, I.V. (2006) Non-Coding RNA. Human Molecular Genetics, 15, R17-R29.
|
[6]
|
Esteller, M. (2011) Non-Coding RNAs in Human Disease. Nature Reviews Genetics, 12, 861-874. https://doi.org/10.1038/nrg3074
|
[7]
|
Huang, Z.P., Ding, Y., Chen, J., Wu, G., Katoaka, M., Hu, Y., et al. (2016) Long Non-Coding RNAs Link Extracellular Matrix Gene Expression to Ischemic Cardiomyopathy. Cardiovascular Research, 112, 543-554.
https://doi.org/10.1093/cvr/cvw201
|
[8]
|
Wahid, F., Shehzad, A., Khan, T. and Kim, Y.Y. (2010) MicroRNAs: Synthesis, Mechanism, Function, and Recent Clinical Trials. Biochimica et Biophysica Acta, 1803, 1231-1243. https://doi.org/10.1016/j.bbamcr.2010.06.013
|
[9]
|
Zorio, E., Medina, P., Rueda, J., Millán, J.M., Arnau, M.A., Beneyto, M., et al. (2009) Insights into the Role of microRNAs in Cardiac Diseases: From Biological Signalling to Therapeutic Targets. Cardiovascular & Hematological Agents in Medicinal Chemistry, 7, 82-90. https://doi.org/10.2174/187152509787047676
|
[10]
|
Kiriakidou, M., Tan, S., Lamprinaki, S., Planell-Saguer, M., Nelson, T. and Mourelatos, Z. (2006) An mRNA m7G Cap Binding-like Motif within Human Ago2 Represses Translation. Cell, 129, 1141-1151. https://doi.org/10.1016/j.cell.2007.05.016
|
[11]
|
Bagga, S., Bracht, H., Massirer, K., Holtz, J., Eachus, R., et al. (2005) Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation. Cell, 122, 553-563.
|
[12]
|
Humphreys, D.T., Westman, B.J., Martin, I.K. and Preiss, T. (2005) MicroRNAs Control Translation Initiation by Inhibiting Eukaryotic Initiation Factor 4E/cap and poly (A) Tail Function. PNAS, 102, 16961-16966.
https://doi.org/10.1073/pnas.0506482102
|
[13]
|
Grey, T.R., Meyers, H., Wu, M.S., Hook, L., et al. (2010) A Viral microRNA Down-Regulates Multiple Cell Cycle Genes through mRNA 5’UTRs. PLOS Pathogens, 6, e1000967.
|
[14]
|
Forman, J., Legesse-Miller, A. and Coller, H. (2008) A Search for Conserved Sequences in Coding Regions Reveals That the let-7 microRNA Targets Dicer within Its Coding Sequence. PNAS, 105, 14879-14884.
https://doi.org/10.1073/pnas.0803230105
|
[15]
|
Thum, C. and Bauersachs, J. (2008) MicroRNAs: Novel Regulators in Cardiac Development and Disease. Cardiovascular Research, 79, 562-570.
https://doi.org/10.1093/cvr/cvn137
|
[16]
|
Lee, C., Feinbaum, R.L. and Ambros, V. (1993) The C. Elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854.
|
[17]
|
Johnson, R.W., Liu, L.Y., Hanna-Rose, W. and Chamberlin, H.M. (2009) The Caenorhabditis Elegans Heterochronic Gene lin-14 Coordinates Temporal Progression and Maturation in the Egg-Laying System. Developmental Dynamics, 238, 394-404.
https://doi.org/10.1002/dvdy.21837
|
[18]
|
Lagos-Quintana, R.R. and Lendeckel, T. (2001) Identification of Novel Genes Coding for Small Expressed RNAs. Science, 294, 853-858.
https://doi.org/10.1126/science.1064921
|
[19]
|
Rybak, A., Fuchs, H., Hadian, K., Smirnova, L., Wulczyn, A.M., et al. (2009) The let-7 Target Gene Mouse lin-41 Is a Stem Cell Specific E3 Ubiquitin Ligase for the miRNA Pathway Protein Ago2. Nature Cell Biology, 11, 1411-1420.
https://doi.org/10.1038/ncb1987
|
[20]
|
Schulman, B.R.M., Esquela-Kerscher, A. and Slack, F.J. (2005) Reciprocal Expression of lin-41 and the microRNAs let-7 and mir-125 during Mouse Embryogenesis. Developmental Dynamics, 234, 1046-1054. https://doi.org/10.1002/dvdy.20599
|
[21]
|
Ren, Z. and Ambros, V.R. (2015) Caenorhabditis Elegans microRNAs of the let-7 Family Act in Innate Immune Response Circuits and Confer Robust Developmental Timing against Pathogen Stress. PNAS, 112, E2366-E2375.
https://doi.org/10.1073/pnas.1422858112
|
[22]
|
Kozomara, A. and Griffiths-Jones, S. (2014) miRBase: Annotating High Confidence microRNAs using Deep Sequencing Data. Nucleic Acids Research, 42, D68-D73.
https://doi.org/10.1093/nar/gkt1181
|
[23]
|
Hausser, B., Rodak, J. and Wirth, Z.M. (2009) MirZ: An Integrated microRNA Expression Atlas and Target Prediction Resource. Nucleic Acid Research, 37, W266-W272.
|
[24]
|
Romain, S.P.R., Tomaszewski, C.G. and Samani, N. (2015) MicroRNAs in Cardiovascular Disease: An Introduction for Clinicians. Heart, 101, 921-928.
https://doi.org/10.1136/heartjnl-2013-305402
|
[25]
|
Da Costa Martins, P.A., Bourajjaj, M., Gladka, M., Kortland, M., Oort, R.J., Pinto, Y.M., et al. (2008) Conditional Dicer Gene Deletion in the Postnatal Myocardium Provokes Spontaneous Cardiac Remodeling. Circulation, 118, 1567-1576.
https://doi.org/10.1161/CIRCULATIONAHA.108.769984
|
[26]
|
Zhao, R.J.F., Li, V., Drehle, M., Muth, A.N., et al. (2007) Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2. Cell, 129, 303-317.
|
[27]
|
Chen, J.F., Murchison, E.P., Tang, R., Callis, E., Tatsuguchi, D., et al. (2008) Targeted Deletion of Dicer in the Heart Leads to Dilated Cardiomyopathy and Heart Failure. PNAS, 105, 2111-2116. https://doi.org/10.1073/pnas.0710228105
|
[28]
|
Rao, P.K., Kumar, R.M., Farkhondeh, B.S. and Lodish, F. (2006) Myogenic Factors That Regulate Expression of Muscle-Specific microRNAs. PNAS, 103, 8721-8726.
https://doi.org/10.1073/pnas.0602831103
|
[29]
|
Xu, C., Lu, Y., Pan, Z., Chu, L., Lin, X., et al. (2007) The Muscle-Specific microRNAs miR-1 and miR-133 Produce Opposing Effects on Apoptosis by Targeting HSP60, HSP70 and Caspase-9 in Cardiomyocytes. Journal of Cell Science, 120, 3045-3052. https://doi.org/10.1242/jcs.010728
|
[30]
|
Zhao, S. and Srivastava, E. (2004) Serum Response Factor Regulates a Muscle-Specific microRNA That Targets Hand2 during Cardiogenesis. Nature, 436, 214-220. https://doi.org/10.1038/nature03817
|
[31]
|
Schindler, G.M., Wang, J., Firulli, A., Firulli, B., Poss, K.D., et al. (2014) Hand2 Elevates Cardiomyocyte Production during Zebrafish Heart. Development, 141, 1-11.
https://doi.org/10.1242/dev.106336
|
[32]
|
Mishima, S.C. and Giraldez, J. (2007) miR-1-2 Gets to the Heart of the Matter. Cell, 129, 247-249.
|
[33]
|
Sayed, D., Hong, C., Chen, I.Y. and Lypowy, A. (2007) MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy. Circulation Research, 100, 416-424. https://doi.org/10.1161/01.RES.0000257913.42552.23
|
[34]
|
Carè, C., Felicetti, F., Bonci, A.A., Gallo, P., et al. (2007) MicroRNA-133 Controls Cardiac Hypertrophy. Nature Medicine, 13, 613-618.
https://doi.org/10.1038/nm1582
|
[35]
|
Liu, B., Williams, H., Qi, R.A., Bassel-Duby, et al. (2008) microRNA-133a Regulates Cardiomyocyte Proliferation and Suppresses Smooth Muscle Gene Expression in the Heart. Genes and Development, 22, 3242-3254.
https://doi.org/10.1101/gad.1738708
|
[36]
|
Xiao, C.Y.H. (2010) MicroRNAs: Novel Regulators of the Heart. Journal of Thoracic Disease, 2, 43-47.
|
[37]
|
Ikeda, H., Kong, L., Bejar, B., et al. (2009) MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes. Molecular and Cellular Biology, 29, 2193-2204. https://doi.org/10.1128/MCB.01222-08
|
[38]
|
Tian, J. and An, N.L. (2017) Role of microRNAs in Cardiac Development and Disease. Experimental and Therapeutic Medicine, 13, 3-8.
https://doi.org/10.3892/etm.2016.3932
|
[39]
|
Rooij, V., Sutherland, B., Qi, R.A. and Hill, O. (2007) Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA. Science, 316, 575-579.
https://doi.org/10.1126/science.1139089
|
[40]
|
Callis, E., Pandya, K., Seok, H.Y., Tang, R.H., Tatsuguchi, M., Huang, Z.P., et al. (2009) MicroRNA-208a Is a Regulator of Cardiac Hypertrophy and Conduction in Mice. The Journal of Clinical Investigation, 119, 2772-2786.
https://doi.org/10.1172/JCI36154
|
[41]
|
Bang, C., Batkai, D., Gupta, F., Holzmann, A., et al. (2014) Cardiac Fibroblast-Derived microRNA Passenger Strand-Enriched Exosomes Mediate Cardiomyocyte Hypertrophy. The Journal of Clinical Investigation, 124, 2136-2146.
https://doi.org/10.1172/JCI70577
|
[42]
|
Rooij, E., Sutherland, B., Liu, W.H., McAnally, G.R.D., et al. (2006) A Signature Pattern of Stress-Responsive microRNAs That Can Evoke Cardiac Hypertrophy and Heart Failure. PNAS, 103, 18255-18260. https://doi.org/10.1073/pnas.0608791103
|
[43]
|
Yang, L., Xiao, L., Luo, L.B., et al. (2007) The Muscle-Specific microRNA miR-1 Regulates Cardiac Arrhythmogenic Potential by Targeting GJA1 and KCNJ2. Nature Medicine, 13, 486-491. https://doi.org/10.1038/nm1569
|
[44]
|
Terentyev, B.E., Terentyeva, M., Malana, E., Kuhn, E., et al. (2009) miR-1 Overexpression Enhances Ca2+ Release and Promotes Cardiac Arrhythmogenesis by Targeting PP2A Regulatory Subunit B56α and Causing CaMKII-Dependent Hyperphosphorylation of RyR2. Cellular Biology, 104, 514-521.
|
[45]
|
Lu, Y., Zhang, W., Pan, G., Zhang, F., et al. (2010) MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation. Circulation, 122, 2378-2387.
|
[46]
|
Girmatsion, B., Bonauer, A., Greinecker, G., Scherer, M.A., et al. (2009) Changes in microRNA-1 Expression and IK1 Up-Regulation in Human Atrial Fibrillation. Heart Rhythm, 6, 1802-1809.
|
[47]
|
Zhenga, X.C.C., Chena, W.D., Shena, W.L., Ruanb, C.C., Zhua, L.M., et al. (2010) MicroRNA-155 Regulates Angiotensin II Type 1 Receptor Expression and Phenotypic Differentiation in Vascular Adventitial Fibroblasts. Biochemical and Biophysical Research Communications, 400, 483-488.
|
[48]
|
Bahring, S., Kann, N., Gong, M., Chitayat, T.R., et al. (2008) Inversion Region for Hypertension and Brachydactyly on Chromosome 12p Features Multiple Splicing and Noncoding RNA. Hypertension, 51, 426-431.
https://doi.org/10.1161/HYPERTENSIONAHA.107.101774
|
[49]
|
Marques, Z., Campain, E., Tomaszewski, Z.-S., Yang, H.J., Charchar, J., et al. (2011) Gene Expression Profiling Reveals Renin mRNA Overexpression in Human Hypertensive Kidneys and a Role for MicroRNAs. Hypertension, 58, 1093-1098.
https://doi.org/10.1161/HYPERTENSIONAHA.111.180729
|
[50]
|
Eskildsen, V., Jeppesen, L., Schneider, N.Y., Sandberg, B., Hansen, P.B.L., et al. (2013) Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans. International Journal of Molecular Science, 14, 11190-11207.
|
[51]
|
Rezaei, A., Neuenschwander, B., Mordasini, D., Frey, F.J., et al. (2014) Regulation of 11β-Hydroxysteroid Dehydrogenase Type 2 by MicroRNA. Hypertension, 64, 860-866. https://doi.org/10.1161/HYPERTENSIONAHA.114.00002
|
[52]
|
Goyal, A., Thomas, N., Davis, R.L., Butler, A., et al. (2010) Predictors of Incident Heart Failure in a Large Insured Population: A One Million Person-Year Follow-Up Study. Circulation: Heart Failure, 3, 698-705.
https://doi.org/10.1161/CIRCHEARTFAILURE.110.938175
|
[53]
|
Goren, K., Zafrir, T., Lewis, S. and Amir, O. (2012) Serum Levels of microRNAs in Patients with Heart Failure. European Journal of Heart Failure, 14, 147-154.
https://doi.org/10.1093/eurjhf/hfr155
|
[54]
|
Devaux, V., McCann, P., Kelly, C., Ng, L., et al. (2013) A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction. PLoS ONE, 8, e70644.
https://doi.org/10.1371/annotation/458a1f6a-6327-429a-81cb-992c97f04bd6
|
[55]
|
Tijsen, J., Creemers, E., Moerland, D., Windt, L.J., Wal, C., Kok, E., et al. (2010) MiR423-5p as a Circulating Biomarker for Heart Failure. Circulation Research, 106, 1035-1039. https://doi.org/10.1161/CIRCRESAHA.110.218297
|
[56]
|
Zhang, N., Ban, T., Xu, L., Wang, N., et al. (2013) Elevated Plasma microRNA-1 Predicts Heart Failure after Acute Myocardial Infarction. International Journal of Cardiology, 166, 259-260.
|
[57]
|
Lai, K.B., Sanderson, E. and Izzat, Y.C.M. (2015) Micro-RNA and mRNA Myocardial Tissue Expression in Biopsy Specimen from Patients with Heart Failure. International Journal of Cardiology, 199, 70-83.
|
[58]
|
Wu, C., So, D.-D.N., Qi, H.H., Bloch, B., Shi, et al. (2011) Hypoxia Potentiates MicroRNA-Mediated Gene Silencing through Posttranslational Modification of Argonaute2. Molecular and Cellular Biology, 11, 4760-4774.
https://doi.org/10.1128/MCB.05776-11
|
[59]
|
Wang, Z., Zhang, L., Chen, M.M., et al. (2012) Loss of the miR-144/451 Cluster Impairs Ischaemic Preconditioning-Mediated Cardioprotection by Targeting Rac-1. Cardiovascular Research, 94, 379-390. https://doi.org/10.1093/cvr/cvs096
|
[60]
|
Corsten, F., Dennert, J.S., Kuznetsova, T., Devaux, Y., Hofstra, L., et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circulation: Cardiovascular Genetics, 3, 499-506.
https://doi.org/10.1161/CIRCGENETICS.110.957415
|
[61]
|
Adachi, N., Otsuka, N.K., Hirokawa, G., et al. (2010) Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction. Clinical Chemistry, 1183-1185.
|
[62]
|
Kuwabara, O., Horie, T., Nishi, N.K., Kinoshita, et al. (2011) Increased microRNA-1 and microRNA-133a Levels in Serum of Patients with Cardiovascular Disease Indicate the Existence of Myocardial Damage. Circulation: Cardiovascular Genetics, 110, 958-975.
|
[63]
|
Matsumoto, S., Suna, S., Nakatani, D., Usami, H.M., et al. (2013) Circulating p53-Responsive MicroRNAs Are Predictive Indicators of Heart Failure after Acute Myocardial Infarction. Circulation Research, 113, 322-326.
https://doi.org/10.1161/CIRCRESAHA.113.301209
|
[64]
|
Hullinger, G., Montgomery, L., Seto, A.G., Dickinson, A., Semus, M., Lynch, M., et al. (2012) Inhibition of miR-15 Protects against Cardiac Ischemic Injury. Circulation Research, 110, 71-81. https://doi.org/10.1161/CIRCRESAHA.111.244442
|
[65]
|
Cardin, S., Guasch, L., Naud, P., Quang, L., Shi, et al. (2012) A Role for MicroRNA-21 in Atrial Profibrillatory Fibrotic Remodeling Associated with Experimental Post-Infarction Heart Failure. Circulation: Arrhythmia and Electrophysiology, 5, 1027-1035. https://doi.org/10.1161/CIRCEP.112.973214
|
[66]
|
Wang, J., Huang, W., Xu, R., Nie, Y., Cao, X., Meng, J., et al. (2012) MicroRNA-24 Regulates Cardiac Fibrosis after Myocardial Infarction. Journal of Cellular and Molecular Medicine, 16, 2150-2160. https://doi.org/10.1111/j.1582-4934.2012.01523.x
|
[67]
|
Glass, K. and Witztum, L. (2001) Atherosclerosis: The Road Ahead. Cell, 104, 503-516.
|
[68]
|
Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., et al. (2010) Circulating MicroRNAs in Patients with Coronary Artery Disease. Circulation Research, 107, 677-684. https://doi.org/10.1161/CIRCRESAHA.109.215566
|
[69]
|
Wei, Y., Nazari-Jahantigh, N. and Weber, C.S. (2013) MicroRNA-126, -145, and -155. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 449-454.
https://doi.org/10.1161/ATVBAHA.112.300279
|
[70]
|
Rayner, J., Sheedy, J., Esau, C., Hussain, N., Temel, E., Parathath, et al. (2011) Antagonism of miR-33 in Mice Promotes Reverse Cholesterol Transport and Regression of Atherosclerosis. The Journal of Clinical Investigation, 121, 2921-2931.
https://doi.org/10.1172/JCI57275
|
[71]
|
Gao, W., He, H.W., Wang, Z.M., Zhao, H., Lian, X.Q., Wang, Y.S., et al. (2012) Plasma Levels of Lipometabolism-Related miR-122 and miR-370 Are Increased in Patients with Hyperlipidemia and Associated with Coronary Artery Disease. Lipids in Health and Disease, 11, 55.
|
[72]
|
Smith, T., Rajakaruna, C., Caputo, M. and Emanueli, C. (2015) MicroRNAs in Congenital Heart Disease. Annals of Translational Medicine, 3, 333.
|
[73]
|
Li, J., Cao, Y., Ma, X.J., Wang, H.J., Zhang, J., Luo, X., et al. (2013) Roles of miR-1-1 and miR-181c in Ventricular Septal Defects. International Journal of Cardiology, 168, 1441-1446.
|
[74]
|
Latronico, M.V.G., Catalucci and Condorelli (2008) MicroRNA and Cardiac Pathologies. Physiological Genomics, 34, 239-242.
https://doi.org/10.1152/physiolgenomics.90254.2008
|
[75]
|
O’Brien, E., Kibiryeva, Zhou, X.G., Marshall, J.A., Lofland, K., Artman, et al. (2012) Noncoding RNA Expression in Myocardium from Infants with Tetralogy of Fallot. Circulation: Cardiovascular Genetics, 5, 279-286.
https://doi.org/10.1161/CIRCGENETICS.111.961474
|
[76]
|
Bittel, C., Kibiryeva, N., Marshall, A. and O’Brien, J.E. (2014) MicroRNA-421 Dysregulation Is Associated with Tetralogy of Fallot. Cells, 3, 713-723.
https://doi.org/10.3390/cells3030713
|
[77]
|
Liang, D., Xu, X., Deng, F., Feng, J., Zhang, H., Liu, Y., et al. (2014) miRNA-940 Reduction Contributes to Human Tetralogy of Fallot Development. Journal of Cellular and Molecular Medicine, 18, 1830-1839. https://doi.org/10.1111/jcmm.12309
|
[78]
|
Nigam, V., Sievers, H., Jensen, C., Sier, A., Simpson, C., Srivastava, D., et al. (2010) Altered Micrornas in Bicuspid Aortic Valve: A Comparison between Stenotic and Insufficient Valves. Journal of Heart Valve Disease, 19, 459-465.
|
[79]
|
Yanagawa, B., Lovren, F., Pan, Y., Garg, V., Quan, A., Tang, G., et al. (2012) MiRNA-141 Is a Novel Regulator of BMP-2-Mediated Calcification in Aortic Stenosis. The Journal of Thoracic and Cardiovascular Surgery, 144, 256-262.
|
[80]
|
Boon, A. and Dimmeler, S. (2015) MicroRNAs in Myocardial Infarction. Nature Reviews Cardiology, 12, 135-142. https://doi.org/10.1038/nrcardio.2014.207
|